Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
Status:
Unknown status
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
- The purpose of this study is to evaluate the efficacy and safety of the application of
bevacizumab combined neoadjuvant chemotherapy in HER2-negative breast cancer.